Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

Laura S. Schmidt(Science Applications International Corporation (United States)), Berton Zbar(National Institutes of Health), Hiltrud Brauch(German Cancer Research Center), W. Marston Linehan(National Institutes of Health), Abi Chidambaram(Science Applications International Corporation (United States)), Ulf R. Bergerheim(National Institutes of Health), Rando Allikmets(Structural Genomics Consortium), Takeshi Kishida(National Institutes of Health), Thomas Stackhouse(Science Applications International Corporation (United States)), Stephen W. Scherer(University of Toronto), Michael Dean(National Cancer Institute), J.T. Feltis(Credit Valley Hospital), Leah Slife(National Institutes of Health), Stephan Störkel(National Institutes of Health), Agustin Zamarron(National Institutes of Health), Marta Bernués(National Institutes of Health), Michael D. Hughson(Northport VA Medical Center), Holger Moch(University of Basel), L. Geil(Science Applications International Corporation (United States)), Jami Lipan(National Institutes of Health), Peter L. Choyke(National Cancer Institute), Fan Chen(Science Applications International Corporation (United States)), C.J.M. Lips(University Medical Center Utrecht), McClellan M. Walther(National Institutes of Health), Lap-Chee Tsui(National Institutes of Health), Michael I. Lerman(National Cancer Institute), Mary Lou Orcutt(National Institutes of Health), Jochen Decker(Johannes Gutenberg University Mainz), Fuh-Mei Duh(Science Applications International Corporation (United States)), Zhenping Zhuang(National Institutes of Health), Gloria A. Niehans(Veterans Health Administration), Irina A. Lubensky(National Institutes of Health), G.M. Glenn(National Institutes of Health), Carme Casadevall(National Institutes of Health)
Nature Genetics
May 1, 1997
Cited by 1,531


Related Papers